The top 10 hit pa­rade of bio­phar­ma li­cens­ing deals for 2014-2017

Last year
Pharma

Who are the top 10 play­ers that dom­i­nate the can­cer drug mar­ket? And who's grow­ing fastest?

Last year
Pharma
R&D

In­sid­ers: The top 20 rare dis­ease spe­cial­ists spot­light key biotech trends be­hind the boom

Last year

R&D trend #5: The top ex­ecs in biotech are rid­ing a boom — but there’s one big step left

Last year

Top trend #4: We’re com­ing to a tip­ping point on can­cer R&D, and it may not be pret­ty

Last year
R&D

The top 5 trends in biotech - #3: High val­u­a­tions for at­trac­tive biotechs are a durable symp­tom of a thriv­ing fi­nanc­ing are­na

Last year

How En­ter­prise cus­tomers can get End­points News in­to their Slack

Last year
Publisher's note

Top 5 bio­phar­ma trends: The long-await­ed bio­phar­ma rev­o­lu­tion in Chi­na has ar­rived — don’t lose out

Last year
China

The top 5 trends re­shap­ing bio­phar­ma starts with an R&D earth­quake

Last year
First page Previous page 123